Cushing's syndrome is a multisystem disorder associated with chronic systemic exposure to excessive amounts of cortisol. It can be induced by both endogenous and exogenous factors and usually presents a typical set of signs and symptoms. Multiple comorbidities of Cushing's syndrome have been identified, which significantly impact the quality of patients' life and contribute to increased mortality.
Even though various effective treatment methods are available, including surgical, radiation-based and pharmacological interventions, recurrence of the disorder is possible. Patients in whom Cushing's syndrome occurred during childhood can retain some physical and psychosocial disadvantage in later life.
This report provides the current prevalent population for Cushing's syndrome across 25 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Finland, Bulgaria, Russia, Turkey, South Africa, Japan, China, South Korea, India, Australia, New Zealand, Brazil, Mexico) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the publisher's analysis team, Cushing's syndrome patients grouped by classification, treatments and comorbidities have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of Cushing's syndrome include:
Obesity
Insulin resistance
Hypertension
Dyslipidaemia
Hypercoagulability leading to VTE
Osteopaenia/osteoporosis
Psychiatric disorders (with aggravation of pre-existing tendencies)
Impaired growth in children
Key Topics Covered:
Introduction
Cause Of The Disease
Risk Factors & Prevention
Diagnosis Of The Disease
Variation By Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Comorbid Conditions / Features Associated With The Disease
The "Global Pediatric Interventional Cardiology Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Pediatric...
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to ResearchAndMarkets.com's...